Our very own Serge Kechichian is all set to tee it up for a cause with colleagues, suppliers, and customers in support of the DCAT (Drug, Chemical & Associated Technologies Association) Scholarship Golf Outing. Under DCAT’s Science and Scholarship Committee’s …
Join J-STAR Research, Inc. Executive Director of Computational Chemistry and Data Science, Yuriy Abramov, Ph.D., as he takes the stage as an invited speaker at the 6th David Grand Symposium on June 15. He will share his insights on computational …
On May 8, 2023, Porton Pharma Solutions Ltd. (stock code: 300363) celebrated the grand opening of its Small Molecule Business Platform Headquarters, located in Minhang Economic and Technological Development Zone, Shanghai. This momentous event attracted nearly 200 representatives ranging from …
On April 11, 2023, Shanghai Porton Nova Biologics, Ltd., a wholly-owned subsidiary of Porton Pharma Solutions Ltd., officially launched the construction of its biologics R&D and manufacturing site in the Waigaoqiao Free Trade Zone of Pudong New Area, Shanghai, China. …
NEW YORK, NY – On March 20th through March 23rd, 2023, Midtown New York City was home to the 95th Annual DCAT Week, one of the world’s largest and highly recognized and attended business events for the pharmaceutical industry. During …
Porton Pharma Solutions Ltd. recently released 2022 CSR Report which is its seventh CSR report since IPO. This report demonstrates the company’s ideas and achievements in fulfilling social responsibility from aspects such as “improving corporate governance”, “providing high-quality services”, “empowering …
Porton Pharma Solutions Ltd. is proud to announce that it has made the top quartile of the S&P Corporate Sustainability Assessment for the first time. On February 28, S&P Global released a new set of S&P Global ESG Scores, where …
Porton’s recognition by Roche is a testament to the high-quality service and technical expertise that comes with working with a leading global end-to-end CDMO.
Shanghai China (December 16, 2022) – Porton Pharma Solutions (hereinafter referred to as Porton) was recently …
J-STAR Research and Porton Pharma Solutions Ltd. are excited to be exhibiting at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting at the Boston Convention Center on October 16th – 19th! Stay tuned for more information regarding our …
The year 2022 is an important milestone for Porton. Despite of the uncertainties of the external environment, we always keep in mind Porton’s mission of “Enabling public’s early access to good medicines” to overcome those challenges and ensure delivery through …
PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life Science Park Mengeš, Slovenia currently owned and operated by Lek Pharmaceuticals d.d., part of NOVARTIS